HEPAVASE MA-96 (TMB) (Anti-HAV IgM)
High-specificity IgM Capture ELISA for acute HAV IgM antibodies. 98% sensitivity, 100% specificity. 10 µL sample, clinically validated, Taiwan DOH certified.
PRODUCT DESCRIPTION
This product is designed as an IgM capture ELISA for detection of acute Hepatitis A virus (HAV) infection. The solid phase is coated with capture antibodies specific for HAV IgM, while the liquid phase includes purified peroxidase-conjugated antibodies. It is optimized to detect early infection through IgM antibodies.
SPECIFICATION
| Number of wells | 96 |
| Principle | IgM Capture |
| Assay format | Qualitative |
| Total incubation time | 150 minutes |
| Sample type | Serum / Plasma |
| Sample volume | 10 μL |
| Reading wavelength | 450nm |
| Storage | 2-8°C |
| Certification | TFDA |
PERFORMANCE
1570 hospitalized patients were tested. The results are as follows：
The diagnostic sensitivity is 98%；The diagnostic specificity is 100%
| Inter-assay precision CV | < 20% | Intra-assay precision CV | < 15% |
|---|
ORDERING INFORMATION
| Catalogue No. | Product |
|---|---|
| 4AME3 | HEPAVASE MA-96 (TMB) |